Author survey results are available now – 89% of respondents highly satisfied or satisfied with overall publishing experience! Further results available at http://mad.ly/3d03c3.

Thank you to our contributors who completed our author survey, we truly value your feedback.

All participants who completed the survey were entered into a draw for a chance to win an iPad mini. The winner of the iPad mini is Dr. Tom Oliver. Congratulations!

Current Oncology, Canada’s premier oncology journal, is now on Twitter!

We invite you to connect with us to receive immediate updates regarding the journal, and the latest in Canadian oncology research.

Thank you to our readers who completed our readership survey, we truly value your feedback.

All participants who completed the survey were entered into a draw for a chance to win an iPad mini. The winner of the iPad mini is Dr. Ryna Levy-Milne from British Columbia. Congratulations!

We have all heard much about the controversial topic of euthanasia, especially during the recent months in Canada.

An editorial titled, “Should there be a legal right to die?” by Dr. David Benatar appeared in the December 2010 issue of Current Oncology, which prompted an opinion piece by Dr. José Pereira titled, “Legalizing euthanasia or assisted suicide: the illusion of safeguards and controls” in the April 2011 issue.

These articles ignited a lot of controversy and compelled Current Oncology to develop a series of special articles dedicated to this timely and very much debated topic of euthanasia and assisted suicide for our readership.

These articles, published in the June issue of Current Oncology, are presented for our readers to review and judge for themselves.

Click on the links below to view articles from this special series.

1. Pereira’s attack on legalizing euthanasia or assisted suicide: smoke and mirrors
2. Casting stones and casting aspersions: let’s not lose sight of the main issues in the euthanasia debate
3. Assisted death and the slippery slope—finding clarity amid advocacy, convergence, and complexity

We invite you to join us in the debate on a timely topic relevant to the medical community! Further correspondence is encouraged, and Current Oncology has the ideal forum: the Cancer Knowledge Network, which opinions can be expressed and where dialogue is encouraged.

The QPCS is a clinic-based study with the goal of characterizing the epidemiologic and hereditary factors associated with pancreatic cancer. Biospecimens are also being collected for biomarker, tumour biology, and cancer microenvironment investigations.

All patients with a diagnosis of pancreatic adenocarcinoma are eligible to participate. If there is a family history of pancreatic cancer, relatives of patients with pancreatic cancer may also participate. Patients and their relatives can be referred to the QPCS using our web site (www.cancerpancreas.ca).

Study participants are asked to complete family and personal history questionnaires and to donate a blood or saliva sample. If a participant lives outside the Montreal area or is unable to attend the QPCS research clinic, collection of samples will be done at or close to the participant’s home. Only patients undergoing surgery at the McGill University Health Centre will be asked to donate a small portion of their resection specimen for tumour biology studies.

Each participant will have an opportunity to discuss the study with a QPCS genetic counsellor. The QPCS is affiliated with McGill University, the McGill University Health Centre and the Rosalind and Morris Goodman Cancer Research Centre.  For more information, please see www.cancerpancreas.ca or contact Dr. George Zogopoulos (george.zogopoulos@mcgill.ca).

Current Oncology Scholars’s Forum & Workshop will be held in May - June 2012, in Guangzhou, China. The forum/workshop welcomes research articles from scientists, doctors and research scholars involved in the area of cancer therapy from all over the world to publish high quality and refereed papers. There will be an issue of Current Oncology publishing accepted papers for this forum/workshop, which are selected through rigorous peer review to ensure originality, timeliness, relevance, and readability. Dr. Qiang Yu, Senior Group Leader, Genome Institute of Singapore, will be the guest editor for this issue. Please follow the relavant link below to format your manuscript http://www.current-oncology.com/index.php/oncology/about/submissions. For paper contribution or other further inquiries, please send email to currentoncology@gmail.com, or current_oncology@hotmail.com.

We would like to welcome to the Current Oncology team, Dr. Yu (Darwin) Cai as our new Associate Editor in China. Dr. Cai is a Professor from Jinan University, Guangzhou, China.

The journal has partnered with Dr. Cai to encourage more submissions to the journal from Chinese Oncologists, as well as expand our online readership in China.

Dr. Cai’s role is to encourage more submissions to the journal through different academic events including conferences, workshops, and seminars.

Contributions from Chinese authors will help to further increase the international reach and impact of the journal.

We look forward to working with Dr. Cai and welcome submissions from his colleagues.

Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective; a supplement to Current Oncology, is now available online!

Optimal Management of Metastatic Colorectal Cancer with the Anti-EGFR Monoclonal Antibodies; a supplement to Current Oncology, is now available online!

Coming soon to Current Oncology! A supplemental issue on the management of Prostate Cancer, edited by Dr. Fred Saad.

Multimed Inc., publisher of Current Oncology, was pleased to attend the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting May 29 to June 2 in Orlando, Florida.